Literature DB >> 29404122

The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease.

Erdal İn1, Mutlu Kuluöztürk1, Önsel Öner1, Figen Deveci1.   

Abstract

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is a common lung disease characterized by airflow limitation and systemic inflammation. Recently, neutrophil-to-lymphocyte ratio (NLR) has gathered increasing interest in the detection of inflammation in inflammatory diseases. This study aimed to investigate the role of NLR in COPD for identifying the detection of inflammation and recognition of acute exacerbation.
MATERIAL AND METHODS: The laboratory results of 103 COPD patients were included into the study, of which 47 patients were in acute exacerbation and 56 patients were at stable period, and there were 40 gender and age-matched healthy controls. Complete blood count (CBC), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were evaluated. NLR was calculated from CBC.
RESULTS: NLR values of patients with COPD (both acutely exacerbated and stable) were found significantly higher than those of the controls (p< 0.001, p< 0.05; respectively). In all patients with COPD, NLR values positively correlated with serum CRP (r= 0.641, p< 0.001) and ESR (r= 0.276, p= 0.005) levels and negatively correlated with forced vital capacity (r= -0.20, p= 0.043) and forced expiratory volume in the 1st second (r= -0.288, p= 0.003). For an NLR cutoff of 3.34, sensitivity for detecting exacerbation of COPD was 78.7% and specificity was 73.2% (AUC 0.863, p< 0.001).
CONCLUSION: Our results suggest that NLR may be considered as a reliable and simple indicator in the determination of increased inflammation in patients with COPD. Furthermore, NLR could be useful for the early detection of possible acute exacerbations in patients with COPD.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; inflammation; neutrophil-to-lymphocyte ratio

Year:  2016        PMID: 29404122      PMCID: PMC5792115          DOI: 10.5578/ttj.17.2.009

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  33 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

Review 2.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

3.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

Authors:  R Zahorec
Journal:  Bratisl Lek Listy       Date:  2001       Impact factor: 1.278

4.  As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio.

Authors:  Ahmet Ahsen; Memnune Sena Ulu; Seref Yuksel; Kasım Demir; Mukremin Uysal; Mujgan Erdogan; Gursel Acarturk
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.

Authors:  Mahsuk Taylan; Melike Demir; Halide Kaya; Hadice Selimoglu Sen; Ozlem Abakay; Ali İhsan Carkanat; Abdurrrahman Abakay; Abdullah Cetin Tanrikulu; Cengizhan Sezgi
Journal:  Clin Respir J       Date:  2015-08-06       Impact factor: 2.570

Review 6.  C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.

Authors:  Andreea L Antonescu-Turcu; Rade Tomic
Journal:  Curr Opin Pulm Med       Date:  2009-03       Impact factor: 3.155

7.  Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

Authors:  Mette Thomsen; Morten Dahl; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2012-09-13       Impact factor: 21.405

8.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; W A Buurman; A J Staal van den Brekel; M A Dentener; E F Wouters
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

9.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Authors:  Mette Thomsen; Truls Sylvan Ingebrigtsen; Jacob Louis Marott; Morten Dahl; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

10.  Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study.

Authors:  Allan Klitgaard Sørensen; Dennis Back Holmgaard; Lone Hagens Mygind; Julia Johansen; Court Pedersen
Journal:  J Inflamm (Lond)       Date:  2015-03-18       Impact factor: 4.981

View more
  3 in total

1.  Influence of disease severity, smoking status and therapy regimes on leukocyte subsets and their ratios in stable chronic obstructive pulmonary disease.

Authors:  Iva Hlapčić; Andrea Vukić Dugac; Sanja Popović-Grle; Ivona Markelić; Ivana Rako; Dunja Rogić; Lada Rumora
Journal:  Arch Med Sci       Date:  2020-11-15       Impact factor: 3.707

2.  Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.

Authors:  Yuliana Pascual-González; Marta López-Sánchez; Jordi Dorca; Salud Santos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-05

3.  Prediction of adverse clinical outcomes in patients with coronavirus disease 2019.

Authors:  Si Shi; Xiaohui Liu; Jinling Xiao; Hongwei Wang; Liyan Chen; Jianing Li; Kaiyu Han
Journal:  J Clin Lab Anal       Date:  2020-09-28       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.